This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Diagnosis, Medication Selection, and Dosing for Specific Indications

Guideline 10: Generalized Anxiety Disorder

 

Published: January 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The features that the experts considered most important in diagnosing generalized anxiety disorder in an older patient agree closely with the DSM-IV criteria. The experts considered excessive anxiety and worry that occur more days than not for at least 6 months the most important discriminating feature.

The experts recommended an antidepressant for the treatment of generalized anxiety disorder (a very high second-line option rated first line by 67% of the experts).’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 65

Quick Links: Anxiety , Anxiolytics

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...